US Bancorp’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-726
Closed -$1.6K 4224
2025
Q1
$1.6K Buy
+726
New +$1.6K ﹤0.01% 3903
2022
Q4
Sell
-4,204
Closed -$18K 4174
2022
Q3
$18K Buy
+4,204
New +$18K ﹤0.01% 3053
2021
Q2
Sell
-350
Closed -$6K 3999
2021
Q1
$6K Hold
350
﹤0.01% 3427
2020
Q4
$7K Buy
350
+67
+24% +$1.34K ﹤0.01% 3284
2020
Q3
$4K Hold
283
﹤0.01% 3295
2020
Q2
$4K Sell
283
-217
-43% -$3.07K ﹤0.01% 3302
2020
Q1
$6K Buy
500
+300
+150% +$3.6K ﹤0.01% 3117
2019
Q4
$5K Hold
200
﹤0.01% 3221
2019
Q3
$4K Sell
200
-3,908
-95% -$78.2K ﹤0.01% 3284
2019
Q2
$76K Buy
4,108
+1,769
+76% +$32.7K ﹤0.01% 2337
2019
Q1
$57K Buy
+2,339
New +$57K ﹤0.01% 2434
2017
Q1
Sell
-41
Closed -$1K 3583
2016
Q4
$1K Buy
+41
New +$1K ﹤0.01% 3450